BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34464855)

  • 1. Generation of integration-free human iPSC line LCPHi001-A from a Parkinson's disease patient carrying the RecNciI mutation in GBA gene.
    Lu X; Song N; Wang W; Liu Y; Song H; Xu L; Wang Y; Wei C; Chen J; Yang X; Han F
    Stem Cell Res; 2021 Oct; 56():102514. PubMed ID: 34464855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human induced pluripotent stem cells line (PNUSCRi002-A) from a patient with Parkinson's disease carrying a R159W mutation in the GBA gene.
    Moon HJ; Lee N; Moon JY; Park KK; Lee JH; Kim JH
    Stem Cell Res; 2022 Dec; 65():102948. PubMed ID: 36274270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
    Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
    Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
    Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
    PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson's disease patient carrying the L444P mutation in the GBA1 gene.
    Rodríguez-Traver E; Rodríguez C; Díaz-Guerra E; Arenas F; Araúzo-Bravo M; Orera M; Kulisevsky J; Moratalla R; Vicario C
    Stem Cell Res; 2019 Oct; 40():101578. PubMed ID: 31539859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
    Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
    Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Parkinson's disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene.
    Lee N; Moon HJ; Park SH; Moon JY; Park KK; Kim JH; Lee JH
    Stem Cell Res; 2022 Dec; 65():102959. PubMed ID: 36332465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of patient-derived pluripotent stem cell-lines and CRISPR modified isogenic controls with mutations in the Parkinson's associated GBA gene.
    X-Q Chen C; Deneault E; Abdian N; You Z; Sirois J; Nicouleau M; Shlaifer I; Villegas L; Boivin MN; Gaborieau L; Karamchandani J; Beitel LK; Fon EA; Durcan TM
    Stem Cell Res; 2022 Oct; 64():102919. PubMed ID: 36130446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an induced pluripotent stem cell line (EURACi014-A) from a Parkinson's disease patient with an A53T mutation in the SNCA gene by an integration-free reprogramming method.
    Gilmozzi V; Gentile G; Riekschnitz DA; Volpato CB; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
    Stem Cell Res; 2022 Apr; 60():102713. PubMed ID: 35189566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
    Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation.
    Lee SY; Jeong S; Kim J; Chung SK
    Stem Cell Res; 2018 Jul; 30():145-149. PubMed ID: 29906669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a pathogenic LRP10/c.688C > T(p.Arg230Trp) mutation.
    Wang Y; Wei C; Liu Y; Lu X; Wang W; Song N; Zhang W; Xu J; Zhang W; Han F
    Stem Cell Res; 2024 Jun; 77():103359. PubMed ID: 38460235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.
    Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
    Stem Cell Res; 2020 Jan; 42():101657. PubMed ID: 31786474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson's disease.
    Yu Z; Wang T; Xu J; Wang W; Wang G; Chen C; Zheng L; Pan L; Gong D; Li X; Qu H; Li F; Zhang B; Le W; Han F
    J Hum Genet; 2015 Feb; 60(2):85-90. PubMed ID: 25518742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene.
    Azevedo C; Chumarina M; Serafimova E; Goldwurm S; Collin A; Roybon L; Savchenko E; Pomeshchik Y
    Stem Cell Res; 2020 Mar; 43():101694. PubMed ID: 31954327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
    Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
    Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.